Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its ADC ...

Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 for post-operative inflammation and pain after ...

The relationship between climate change and infectious disease is raising new questions for pharmaceutical and clinical ...

This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024 ...

There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.

The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.

Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.

The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).

Outlook Therapeutics ’ second attempt to obtain US approval for its wet age-related macular degeneration (wet AMD) therapy, ...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics for rare genetic disease ...

With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative ...

In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic ...